Skip to content
Back
  • Home
  • About us
    • Company focus
    • Management
    • Board
    • Team
    • Scientific advisory board
    • Partnerships
    • Investors
  • Our science
    • R&D Focus
    • R&D Levers
  • Pipeline
    • Pipeline
    • JM-010
    • CP-012
    • Discovery
  • News
    • Press releases
    • Upcoming events
  • Contact
    • Business Development
    • Social network

About
Contera Pharma

Learn about us

Foundation and core beliefs

Lightbulb icon

Our Ambition

Neurological disorders are devastating and complex conditions with limited treatment options. By applying our innovative platform technology, we seek to create novel solutions for life-changing therapeutics to patients in medical need.

Thinking icon

Our Foundation

Our employees are the foundation for the growth and progress of Contera Pharma. We are agile, ambitious and committed to make a difference for patients. We seek synergies in partnerships and collaborations to accomplish our goals.

Atom icon

Our Science

We are focused on creating a de-risked portfolio of projects aimed at human validated targets. Our scientific capacity and pharma knowledge base serve as strong levers for unraveling both the molecular mechanisms as well as solving the pharmacological challenges in disease.

 

Discover our team

Recent News

September 27, 2022
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S announce a strategic collaboration in the field of RNA-targeting small molecules in neurology
Cambridge UK, and Copenhagen, Denmark, 27 September 2022 – Vernalis Research (“Vernalis”), a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S (“Contera”)…
Read more
September 08, 2022
Contera Pharma signs agreement with BDD Pharma for development of a novel tablet formulation to treat nocturnal symptoms and morning akinesia in Parkinson´s disease
Contera Pharma, a biotech company developing innovative therapies to treat neurological disorders, has entered into collaboration with BDD Pharma, a drug delivery…
Read more

View all news

Contact us

Denmark map icon

Contera Pharma Headquarter

Contera Pharma A/S
Venlighedsvej 4
2970 Hørsholm
Denmark

Thomas Sager, CEO
info@conterapharma.com

South Korea map icon

Contera Pharma Korea

7, SangDo-Ro, Dongjak-Gu
Seoul, 06955
Korea

info@conterapharma.com

Contact us

Contera Pharma Headquarter

Contera Pharma A/S
Venlighedsvej 4
2970 Hørsholm
Denmark

 

Thomas Sager, CEO

info@conterapharma.com

Contera Pharma Korea

7, SangDo-Ro,

Dongjak-Gu

Seoul, 06955

Korea

info@conterapharma.com

Connect on Linkedin

Useful links

About us

Our Science

Pipeline

News

Contact

Cookie policy

Privacy policy

Bukwang

Bukwang Pharmaceutical Co., Ltd. was established on October 17th, 1960 and has since continued to produce excellent medications with the aim of improving global health for the last 55 years.

Discover Bukwang

Designet af Standoutmedia